Search research articles
Contact Us
Filters
Showing results (21-30 of 34) with videos related to
Page
of 4
Sort By:
Immunology
|
May 1, 1981
Evidence for the presence of a low molecular-weight activator of suppressor monocytes (LASM) in dialysates of T lymphocytes
K Nekam, A J Strelkauskas, H H Fudenberg, et al.
Cerebrovascular Diseases (Basel, Switzerland)
|
September 24, 2008
Economic evaluation alongside a phase II, multi-centre, randomised controlled trial of very early rehabilitation after stroke (AVERT)
K Tay-Teo, M Moodie, J Bernhardt, et al.
Stroke
|
August 2, 2003
Perfusion thresholds in acute stroke thrombolysis
K Butcher, M Parsons, T Baird, et al.
Cerebrovascular Diseases (Basel, Switzerland)
|
July 31, 2009
Very early mobilisation and complications in the first 3 months after stroke: further results from phase II of A Very Early Rehabilitation Trial (AVERT)
D Sorbello, H M Dewey, L Churilov, et al.
Neurology
|
February 26, 2010
Sex differences in presentation, severity, and management of stroke in a population-based study
S L Gall, G Donnan, H M Dewey, et al.
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia
|
June 10, 2000
Echoplanar magnetic resonance imaging in acute stroke
S Davis, B Tress, P A Barber, et al.
Stroke
|
July 7, 2001
Hypertension in acute stroke: what to do?
P Bath, G Boysen, G Donnan, et al.
International Journal of Cancer
|
November 1, 1994
Dietary factors and the risk of glioma in adults: results of a case-control study in Melbourne, Australia
G G Giles, J J McNeil, G Donnan, et al.
Journal of the Neurological Sciences
|
December 1, 1996
Mitochondrial DNA polymorphism in substantia nigra
R M Kapsa, M J Jean-Francois, P Lertrit, et al.
Stroke
|
December 13, 2003
Effects of a perindopril-based blood pressure-lowering regimen on the risk of recurrent stroke according to stroke subtype and medical history: the PROGRESS Trial
N Chapman, R Huxley, C Anderson, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 34) with videos related to
Sort By:
Page
of 4
Immunology
|
May 1, 1981
Evidence for the presence of a low molecular-weight activator of suppressor monocytes (LASM) in dialysates of T lymphocytes
K Nekam, A J Strelkauskas, H H Fudenberg, et al.
Cerebrovascular Diseases (Basel, Switzerland)
|
September 24, 2008
Economic evaluation alongside a phase II, multi-centre, randomised controlled trial of very early rehabilitation after stroke (AVERT)
K Tay-Teo, M Moodie, J Bernhardt, et al.
Stroke
|
August 2, 2003
Perfusion thresholds in acute stroke thrombolysis
K Butcher, M Parsons, T Baird, et al.
Cerebrovascular Diseases (Basel, Switzerland)
|
July 31, 2009
Very early mobilisation and complications in the first 3 months after stroke: further results from phase II of A Very Early Rehabilitation Trial (AVERT)
D Sorbello, H M Dewey, L Churilov, et al.
Neurology
|
February 26, 2010
Sex differences in presentation, severity, and management of stroke in a population-based study
S L Gall, G Donnan, H M Dewey, et al.
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia
|
June 10, 2000
Echoplanar magnetic resonance imaging in acute stroke
S Davis, B Tress, P A Barber, et al.
Stroke
|
July 7, 2001
Hypertension in acute stroke: what to do?
P Bath, G Boysen, G Donnan, et al.
International Journal of Cancer
|
November 1, 1994
Dietary factors and the risk of glioma in adults: results of a case-control study in Melbourne, Australia
G G Giles, J J McNeil, G Donnan, et al.
Journal of the Neurological Sciences
|
December 1, 1996
Mitochondrial DNA polymorphism in substantia nigra
R M Kapsa, M J Jean-Francois, P Lertrit, et al.
Stroke
|
December 13, 2003
Effects of a perindopril-based blood pressure-lowering regimen on the risk of recurrent stroke according to stroke subtype and medical history: the PROGRESS Trial
N Chapman, R Huxley, C Anderson, et al.
Page
of 4